Virus and Vaccine News To Drive Markets This Week
Virus Trends Regain Spotlight
With the election results coming into clearer focus, even though the Senate remains uncertain until Georgia’s twin run-offs on January 5, for now investors are assuming the Senate will stay in Republican hands and that has their attention returning squarely to the virus. The outlook on vaccines, case trends and hospitalizations will be the leading factors driving trading. Moderna’s upbeat news on their vaccine trials has the market in risk-on mode this morning, but the investors assumes case trends will get worse in the near-term, especially as Thanksgiving and Christmas bring groups together and just as the winter weather starts to bite keeping more of us indoors. The question will be whether trends accelerate to the point that some localized lockdowns will be necessary. We’ve learned a lot about the virus since March so full-scale lockdowns, with the attendant economic damage, are probably not in the cards, but certainly frontline service businesses could face a bitter winter if trends worsen significantly. Away from the virus news, this week will bring October results for retail sales (Tuesday), Leading Index (Friday), Housing Starts and Permits (Thursday) and Existing Home Sales (Friday). All are expected to post similar results to September and they were decent to good.
|Treasury Curve||Today||Week Change|
|3 Mo LIBOR||0.22%|
|6 Mo LIBOR||0.25%|
|12 Mo LIBOR||0.34%|
|Date||Statistic||For||Briefing Forecast||Market Expects||Prior|
|Nov 16||Empire Manufacturing||Nov||13.8||13.5||10.5|
|Nov 17||Advance Retail Sales MoM||Oct||0.5%||0.5%||1.9%|
|Nov 17||Retail Sales Control Group MoM||Oct||0.5%||0.5%||1.4%|
|Nov 17||Industrial Production MoM||Oct||1.0%||1.0%||-0.6%|
|Nov 18||Housing Starts MoM||Oct||2.8%||3.0%||1.9%|
|Nov 18||Building Permits MoM||Oct||1.4%||1.5%||4.7%|
|Nov 19||Philly Fed Business Outlook||Nov||22.0||22.0||32.3|
|Nov 19||Leading Index||Oct||0.7%||0.7%||0.7%|
|Nov 19||Existing Home Sales MoM||Oct||-1.4%||-1.4%||9.4%|
Nov. 16 — 20, 2020
1. Virus Outlook—All Week
2. October Retail Sales—Tuesday
3. October Leading Index—Friday
4. October Housing Starts & Permits—Thursday
5. October Existing Home Sales—Friday
With the election results coming into clearer focus, even though the Senate remains uncertain until Georgia’s twin run-offs on January 5, for now investors are assuming the Senate will stay in Republican hands, and that has their attention returning squarely to the virus. The outlook on case trends and hospitalizations will be the leading factors driving trading. The market assumes case trends will get worse in the near-term, especially as Thanksgiving and Christmas bring groups together and just as the winter weather starts to bite keeping more of us indoors. The question really will be whether the trends accelerate to the point that some partial, or localized, lockdowns will be necessary. We’ve learned a lot about the virus since March so full-scale lockdowns, with the attendant economic damage, are probably not in the cards, but certainly frontline service businesses could face a bitter winter if trends worsen significantly. While the vaccine news last week from Pfizer was positive, and Moderna posted similar results for their drug this morning but wide-spread inoculations are still a late spring to early summer event. What happens between now and then with the virus, and the need or not to implement lockdowns, will dictate much of the trading into year-end.
2. October Retail Sales —Tuesday
Perhaps second to the monthly jobs reports the Advance Retail Sales Report is a first-tier indicator of the health of the consumer and hence the economy. For October, sales are expected to be up 0.5% versus a huge 1.9% surprise in September. Sales ex-auto and gas are expected to stay positive but slow with an 0.6% reading versus 1.5% in September. The retail sales Control Group—a direct feed into GDP—is expected to be up 0.5% versus 1.4% in September. Thus, if expectations are met some weakening in sales versus an unusually strong September but still easily positive and that will be a note of encouragement to fourth quarter growth expectations. Currently, the Bloomberg consensus is for fourth quarter GDP to be 4.0%.
3. October Leading Index—Friday
The Leading Index plumbed new depths in March and April, as one would expect, but rebounded smartly in May and June while July and August saw a little fade from the May/June bounce. For October the index is expected to repeat the September numbers with a 0.7% print. The stock rally is helping to hold up the index but the threat of increasing virus cases and slowing in reopening activity is limiting gains in the index. Still, hanging above 0 is an accomplishment right now so we’ll take it.
4. October Housing Starts & Permits —Wednesday
The housing market is one sector of the economy that has kept up the momentum from June though the summer, and October is expected to continue gaining after a bit of a pause in August. Starts are expected to increase 3.0% to 1.457 million units annualized versus September’s 1.9% gain or 1.415 million units annualized. Permits are expected to increase 1.5% increase to 1.568 million annualized versus 1.545 million in September. So a solid read is expected for October, slightly better than September and that speaks to the continuing strength in all segments of the housing market.
5. October Existing Home Sales—Friday
On Friday we’ll get October existing home sales—accounting for 90% of the residential marke —which are expected to be down slightly from a huge September number shrinking –1.4% to 6.45 million houses from 6.54 sold on an annualized basis. The housing sector continues to benefit from record low mortgage rates and the October numbers should continue to show a housing market hitting on all cylinders. The 6.54 million annualized figure in September was the largest since December 2006 when sales were coming off the extremes of the housing bubble that peaked at 7.25 million annualized units sold in September 2005.
Securities offered through the SouthState | DuncanWilliams 1) are not FDIC insured, 2) not guaranteed by any bank, and 3) may lose value including a possible loss of principal invested. SouthState | DuncanWilliams does not provide legal or tax advice. Recipients should consult with their own legal or tax professionals prior to making any decision with a legal or tax consequence. The information contained in the summary was obtained from various sources that SouthState | DuncanWilliams believes to be reliable, but we do not guarantee its accuracy or completeness. The information contained in the summary speaks only to the dates shown and is subject to change with notice. This summary is for informational purposes only and is not intended to provide a recommendation with respect to any security. In addition, this summary does not take into account the financial position or investment objectives of any specific investor. This is not an offer to sell or buy any securities product, nor should it be construed as investment advice or investment recommendations.